Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 26, 2007, doi:10.1212/01.wnl.0000278388.90370.c3)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow CME: Take the course for this article:
Volume 70, Number 7, February 12, 2008
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000278388.90370.c3v1
70/7/504    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iizuka, T.
Right arrow Articles by Dalmau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iizuka, T.
Right arrow Articles by Dalmau, J.
Received April 12, 2007
Accepted June 1, 2007

Anti-NMDA receptor encephalitis in Japan. Long-term outcome without tumor removal

T. Iizuka MD*, F. Sakai MD, T. Ide MD, T. Monzen MD, S. Yoshii MD, M. Iigaya MD, K. Suzuki MD, D. R. Lynch MD, PhD, N. Suzuki MD, T. Hata MD, and J. Dalmau MD, PhD

From the Department of Neurology, School of Medicine, Kitasato University, Kanagawa, Japan (T. Iizuka, F.S., T. Ide, T.M., S.Y., M.I., K.S.); Department of Neurology, Divisions of Neuro-oncology and Pediatric Neurology, University of Pennsylvania, Philadelphia, PA (D.R.L., J.D.); Department of Neurology, School of Medicine, Keio University, Tokyo, Japan (N.S.); and Department of Neurology, Shizuoka Municipal Shimizu Hospital, Shizuoka, Japan (T.H.).


* To whom correspondence should be addressed. E-mail: takahiro{at}med.kitasato-u.ac.jp.

ABSTRACT

Objective: To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with "juvenile acute nonherpetic encephalitis" of unclear etiology, and to describe their long-term follow-up in the absence of tumor resection.

Methods: We extensively reviewed the case histories with current clinical and laboratory evaluations that include testing for antibodies to NR1/NR2 heteromers of the NMDAR in serum/CSF available from the time of symptom onset (4 to 7 years ago) and the present.

Results: All patients sequentially developed prodromal symptoms, psychosis, hypoventilation, severe orofacial dyskinesias, and bizarre immunotherapy-resistant involuntary movements that lasted 1 to 12 months. Two patients required mechanical ventilation for 6 and 9 months. Initial tests were normal or unrevealing, including the presence of nonspecific CSF pleocytosis, and normal or mild changes in brain MRI. Eventually, all patients had dramatic recovery of cognitive functions, although one had bilateral leg amputation due to systemic complications. Antibodies to NR1/NR2 heteromers were found in archived serum or CSF but not in long-term follow-up samples. An ovarian teratoma was subsequently demonstrated in three patients (all confirmed pathologically).

Conclusion: 1) These findings indicate that "juvenile acute nonherpetic encephalitis" or a subset of this disorder is mediated by an antibody-associated immune response against NR1/NR2 heteromers of the NMDA receptor (NMDAR). 2) Our patients’ clinical features emphasize that anti-NMDAR encephalitis is severe but potentially reversible and may precede by years the detection of an ovarian teratoma. 3) Although recovery may occur without tumor removal, the severity and extended duration of symptoms support tumor removal.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
M. Fink and M. A. Taylor
The Catatonia Syndrome: Forgotten but Not Gone
Arch Gen Psychiatry, November 1, 2009; 66(11): 1173 - 1177.
[Full Text] [PDF]


Home page
Arch NeurolHome page
P. Niehusmann, J. Dalmau, C. Rudlowski, A. Vincent, C. E. Elger, J. E. Rossi, and C. G. Bien
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women With New-Onset Epilepsy
Arch Neurol, April 1, 2009; 66(4): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
M Schimmel, C G Bien, A Vincent, W Schenk, and J Penzien
Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia
Arch. Dis. Child., April 1, 2009; 94(4): 314 - 316.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
A. R. Foster and J. P. Caplan
Paraneoplastic Limbic Encephalitis
Psychosomatics, March 1, 2009; 50(2): 108 - 113.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Ishiura, S. Matsuda, M. Higashihara, M. Hasegawa, A. Hida, R. Hanajima, T. Yamamoto, J. Shimizu, J. Dalmau, and S. Tsuji
RESPONSE OF ANTI-NMDA RECEPTOR ENCEPHALITIS WITHOUT TUMOR TO IMMUNOTHERAPY INCLUDING RITUXIMAB
Neurology, December 2, 2008; 71(23): 1921 - 1923.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Eker, E Saka, J Dalmau, A Kurne, C Bilen, H Ozen, D Ertoy, K K Oguz, and B Elibol
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1082 - 1083.
[Full Text] [PDF]


Home page
NEJMHome page
T. D. Sabin, J. A. Jednacz, and P. N. Staats
Case 26-2008 -- A 26-Year-Old Woman with Headache and Behavioral Changes
N. Engl. J. Med., August 21, 2008; 359(8): 842 - 853.
[Full Text] [PDF]


Home page
NeurologyHome page
F. Graus and A. Saiz
Limbic encephalitis: An expanding concept
Neurology, February 12, 2008; 70(7): 500 - 501.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.